Homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5HIAA) during L-dopa therapy of Parkinson's disease.
D003704:Dementia / Q000097:blood / Q000188:drug therapy; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use*; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid*; D010300:Parkinson Disease / Q000097:blood / Q000134:cerebrospinal fluid / Q000188:drug therapy*; D010648:Phenylacetates / Q000097:blood / Q000134:cerebrospinal fluid*; D011339:Probenecid / Q000494:pharmacology
D010648:Phenylacetates; D006897:Hydroxyindoleacetic Acid; D004295:Dihydroxyphenylalanine; D011339:Probenecid